Search for: "Boehringer Ingelheim"
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
HSMN NewsFeed,
4 Aug 2010:
Biopharmaceuticals, Personnel[Watson Pharmaceuticals]
Sun Pharma Announces USFDA Approval for Generic Flomax(R)
HSMN NewsFeed,
16 Jul 2010:
Biopharmaceuticals, Generics, FDA[Sun Pharmaceutical Industries, tamsulosin, Flomax, Boehringer Ingelheim]
Exelixis Regains Full Rights to Develop and Commercialize XL184
HSMN NewsFeed,
21 Jun 2010:
Biopharmaceuticals[Exelixis, Bristol-Myers Squibb, XL184, MET inhibitor]
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
HSMN NewsFeed,
26 May 2010:
Biopharmaceuticals, Personnel[Pfizer]
Teva Announces Launch of Generic Flomax(R)
HSMN NewsFeed,
28 Apr 2010:
Biopharmaceuticals, Generics, Urology, FDA[Teva Pharmaceutical, Tamsulosin, Boehringer Ingelheim, Flomax]
Mylan Receives Approval for Generic Version of Flomax(R)
HSMN NewsFeed,
28 Apr 2010:
Biopharmaceuticals, Generics, Urology, FDA[Mylan, Mylan Pharmaceuticals, Tamsulosin, Boehringer Ingelheim, Flomax]
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
HSMN NewsFeed,
19 Apr 2010:
Biopharmaceuticals, Generics, FDA[Roxane Laboratories, Boehringer Ingelheim, imipramine, TOFRANIL, Mallinckrodt]
FDA Maintains Essential Use Status of Combivent(R) (ipratropium bromide and albuterol sulfate) Inhalation Aerosol Through 2013
HSMN NewsFeed,
13 Apr 2010:
Biopharmaceuticals, FDA[Boehringer Ingelheim, Combivent, ipratropium, albuterol, COPD]
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
HSMN NewsFeed,
23 Mar 2010:
Biopharmaceuticals, FDA, Neurology[Boehringer Ingelheim Pharmaceuticals, Mirapex ER, Parkinson's disease]
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment
HSMN NewsFeed,
2 Mar 2010:
Biopharmaceuticals, FDA, Generics[Impax Laboratories, tamsulosin, FLOMAX, Boehringer Ingelheim, Astellas Pharma]
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
HSMN NewsFeed,
22 Feb 2010:
Biopharmaceuticals, Neurology, FDA[Boehringer Ingelheim, Mirapex, pramipexole, Parkinson's disease]
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
HSMN NewsFeed,
9 Feb 2010:
Biopharmaceuticals, Personnel[Xencor]
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
HSMN NewsFeed,
25 Jan 2010:
Biopharmaceuticals, Personnel[Acorda Therapeutics, AMPYRA, dalfampridine]
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
HSMN NewsFeed,
8 Jan 2010:
Biopharmaceuticals, Personnel[Genzyme]
Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
HSMN NewsFeed,
31 Dec 2009:
Biopharmaceuticals, Mergers & Acquisitions[Anika Therapeutics, Fidia Advanced Biopolymers, hyaluronic acid]
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Drug Delivery, FDA[Pfizer, Boehringer Ingelheim, SPIRIVA, HandiHaler, tiotropium bromide, COPD]
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
HSMN NewsFeed,
7 Dec 2009:
Biopharmaceuticals, Personnel[Xencor, Protein Design Automation, XmAb]
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
HSMN NewsFeed,
19 Nov 2009:
Biopharmaceuticals, Dermatology, Regulatory[Anika Therapeutics, hyaluronic acid, ELEVESS, ELEVESS Light]
Watson Names Robert A. Stewart Senior Vice President, Global Operations
HSMN NewsFeed,
16 Nov 2009:
Biopharmaceuticals, Personnel[Watson Pharmaceuticals]
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
HSMN NewsFeed,
19 Oct 2009:
Biopharmaceuticals, Cardiology, FDA[Boehringer Ingelheim, Micardis, telmisartan, Twynsta, telmisartan, amlodipine]
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition
HSMN NewsFeed,
14 Oct 2009:
Biopharmaceuticals, Mergers & Acquisitions[Pfizer, Wyeth]
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
HSMN NewsFeed,
14 Oct 2009:
Biopharmaceuticals, Personnel[XOMA]
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
HSMN NewsFeed,
5 Oct 2009:
Biopharmaceuticals, Urology, Generics, FDA[Impax Laboratories, FLOMAX, tamsulosin, Boehringer Ingelheim]
Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin
HSMN NewsFeed,
29 Sep 2009:
Biopharmaceuticals, Endocrinology[Boehringer Ingelheim Pharmaceuticals, linagliptin]
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
HSMN NewsFeed,
18 Aug 2009:
Biopharmaceuticals, Generics, FDA[Par Pharmaceutical, Aveva Drug Delivery Systems, clonidine transdermal system]
Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
HSMN NewsFeed,
28 Jul 2009:
Biopharmaceuticals, Personnel[Laureate Pharma]
Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
HSMN NewsFeed,
6 Jul 2009:
Devices, Dermatology[Coapt Systems, Hydrelle, hyaluronic acid, dermal filler]
Anika Therapeutics Appoints Frank J. Luppino as Chief Operating Officer
HSMN NewsFeed,
26 May 2009:
Biopharmaceuticals, Personnel[Anika Therapeutics]
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
HSMN NewsFeed,
21 May 2009:
Biopharmaceuticals[AstraZeneca, budesonide/formoterol, Symbicort]
Eurand Appoints Dr. Robert Becker as Chief Research Officer
HSMN NewsFeed,
28 Apr 2009:
Biopharmaceuticals, Personnel[Eurand]
Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
HSMN NewsFeed,
31 Mar 2009:
Biopharmaceuticals, Cardiology[Boehringer Ingelheim, atrial fibrillation, stroke]
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
HSMN NewsFeed,
30 Mar 2009:
Biopharmaceuticals, Neurology, Personnel[BrainCells]
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
HSMN NewsFeed,
20 Mar 2009:
Biopharmaceuticals, Cardiology[Boehringer Ingelheim, dabigatran etexilate, atrial fibrillation]
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
HSMN NewsFeed,
2 Mar 2009:
Biopharmaceuticals, Regulatory[Orexo, Abstral, ProStrakan, Rapinyl, breakthrough cancer pain]
Break-through Drug for Heart Failure in Dogs Now Available in the United States
HSMN NewsFeed,
17 Feb 2009:
Biopharmaceuticals, Cardiology[Boehringer Ingelheim Vetmedica, Boehringer Ingelheim, Vetmedin, pimobendan]
Axikin Pharmaceuticals Spins out of Actimis
HSMN NewsFeed,
22 Jan 2009:
Biopharmaceuticals, Venture Capital[Axikin Pharmaceuticals, Actimis Pharmaceuticals]
Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines
HSMN NewsFeed,
12 Jan 2009:
Biopharmaceuticals, Personnel[Boehringer Ingelheim]
Abstral receives marketing approval in Germany
HSMN NewsFeed,
11 Dec 2008:
Biopharmaceuticals, Regulatory[Orexo, ProStrakan Group, Abstral, Rapinyl, fentanyl]
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
HSMN NewsFeed,
10 Dec 2008:
Biopharmaceuticals[Eli Lilly, Cymbalta, duloxetine, Depression]
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed,
10 Dec 2008:
Biopharmaceuticals, Personnel[MorphoSys]
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed,
26 Nov 2008:
Biopharmaceuticals[MorphoSys, Galapagos NV, antibodies, arthritis]
Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
HSMN NewsFeed,
25 Sep 2008:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, ECASS 3, Actilyse, alteplase, stroke]
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
HSMN NewsFeed,
24 Sep 2008:
Biopharmaceuticals, Regulatory[Boehringer Ingelheim, Pradaxa, dabigatran etexilate, venous thromboembolism, VTE]
Anika Therapeutics Announces Exclusive Latin America Distribution Agreement for ORTHOVISC Products with DePuy Mitek
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Orthopaedic[Anika Therapeutics, DePuy Mitek, ORTHOVISC, osteoarthritis]
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed,
22 Aug 2008:
Biopharmaceuticals, Regulatory[Eli Lilly, Cymbalta, duloxetine]
NewCardio Names Ihor Gussak, M.D., Ph.D., FACC Chief Medical Officer
HSMN NewsFeed,
5 Aug 2008:
Devices, Cardiology, Personnel[NewCardio]
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
HSMN NewsFeed,
31 Jul 2008:
Biopharmaceuticals, Licensing[Orexo, ProStrakan Group, Rapinyl, Abstral, Endo Pharmaceuticals]
Roxane Laboratories, Inc. Initiates a Nationwide Voluntary Recall of Two Manufacturing Lots of Sodium Polystyrene Sulfonate Suspension in the US and Puerto Rico
HSMN NewsFeed,
14 Jul 2008:
Biopharmaceuticals, Product Recall[Roxane Laboratories, Sodium Polystyrene Sulfonate]
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
HSMN NewsFeed,
8 Jul 2008:
Devices, Dermatology, Distribution[Anika Therapeutics, Artes Medical, ELEVESS, dermal filler, hyaluronic acid]
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
HSMN NewsFeed,
30 Jun 2008:
Devices, Orthopaedic[Anika Therapeutics, MONOVISC, hyaluronic acid, viscosupplement, osteoarthritis]
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed,
27 Jun 2008:
Biopharmaceuticals, Regulatory[Eli Lilly, Cymbalta, duloxetine, Generalised Anxiety Disorder]
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
HSMN NewsFeed,
16 Jun 2008:
Biopharmaceuticals, Oncology, Licensing[MorphoSys AG, OncoMed Pharmaceuticals, cancer stem cells]
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Mirapexin, Sifrol, Restless Legs Syndrome]
Orexo Strengthens the Executive Management Group
HSMN NewsFeed,
9 Jun 2008:
Biopharmaceuticals, Personnel[Orexo]
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, Personnel[MedImmune]
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
HSMN NewsFeed,
24 Apr 2008:
Biopharmaceuticals, Generics, FDA[Lannett Company, Dipyridamole, Persantine, Boehringer Ingelheim]
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
HSMN NewsFeed,
21 Apr 2008:
Devices, Personnel[Nephros]
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
HSMN NewsFeed,
17 Apr 2008:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Mirapexin, Sifrol, Restless Legs Syndrome]
Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population. From ONTARGET(R) it May be Concluded That Telmisartan can Prevent Every 5th Serious Cardiovascular Event
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Cardiology[Boehringer Ingelheim, ONTARGET Trial, telmisartan, MICARDIS]
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
HSMN NewsFeed,
27 Mar 2008:
Biopharmaceuticals, Regulatory[Boehringer Ingelheim, thrombin inhibitor, VTE, Pradaxa, dabigatran etexilate]
Icagen Announces Senior Management Promotions
HSMN NewsFeed,
19 Mar 2008:
Biopharmaceuticals, Personnel[Icagen]
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
HSMN NewsFeed,
10 Mar 2008:
Biopharmaceuticals, Personnel[Elusys Therapeutics]
Orexo: Rapinyl(TM) has Received Swedish Marketing Authorization
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Regulatory, Drug Delivery[Orexo, Rapinyl, Abstral, ProStrakan, sublingual fentanyl]
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
HSMN NewsFeed,
19 Feb 2008:
Biopharmaceuticals, Generics, FDA[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Mirapex]
Anika Therapeutics Launches ORTHOVISC(R) mini in Europe
HSMN NewsFeed,
13 Feb 2008:
Biopharmaceuticals, Orthopaedic[Anika Therapeutics, ORTHOVISC mini, ORTHOVISC, osteoarthritis]
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
HSMN NewsFeed,
31 Jan 2008:
Biopharmaceuticals, Urology, Generics, FDA[Teva Pharmaceutical, Tamsulosin, Boehringer Ingelheim, Flomax, BPH]
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
HSMN NewsFeed,
29 Jan 2008:
Biopharmaceuticals, Personnel[Anika Therapeutics]
Knopp Neurosciences Completes First Series B Financing of $10 Million
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Venture Capital[Knopp Neurosciences]
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
HSMN NewsFeed,
20 Dec 2007:
Biopharmaceuticals, Personnel[Pearl Therapeutics]
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
HSMN NewsFeed,
19 Dec 2007:
Biopharmaceuticals, Personnel[Curis]
Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
HSMN NewsFeed,
28 Nov 2007:
Biopharmaceuticals, HIV/AIDS[Boehringer Ingelheim, NEwArT study, VIRAMUNE]
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
HSMN NewsFeed,
20 Nov 2007:
Biopharmaceuticals, Dermatology, Licensing[Anika Therapeutics, Galderma, ELEVESS]
Ranbaxy Launches Ran(R)-Tamsulosin Hydrochloride Capsules in Canada
HSMN NewsFeed,
20 Nov 2007:
Biopharmaceuticals, Generics, Regulatory[Ranbaxy Pharmaceuticals, Tamsulosin, Flomax, Boehringer Ingelheim]
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals, Generics, Litigation[Ranbaxy Laboratories, Astellas Pharma, Boehringer Ingelheim, Flomax, tamsulosin]
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals, Generics, Litigation[Boehringer Ingelheim, Astellas Pharma, Flomax, tamsulosin]
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Generics, FDA[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Mirapex]
Altus Pharmaceuticals Announces Management Changes
HSMN NewsFeed,
29 Oct 2007:
Biopharmaceuticals, Personnel[Altus Pharmaceuticals]
Xencor Expands Series E Financing to $60 Million
HSMN NewsFeed,
25 Oct 2007:
Biopharmaceuticals, Venture Capital[Xencor, XmAb]
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer
HSMN NewsFeed,
25 Oct 2007:
Biopharmaceuticals, Personnel[Xencor]
Medarex Announces the Appointment of Ursula B. Bartels as Senior Vice President, General Counsel and Secretary
HSMN NewsFeed,
17 Oct 2007:
Biopharmaceuticals, Personnel[Medarex]
Evotec to Acquire Renovis, Seek NASDAQ Listing
HSMN NewsFeed,
19 Sep 2007:
Biopharmaceuticals, Mergers & Acquisitions[Evotec, Renovis]
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, Personnel[Anika Therapeutics]
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
HSMN NewsFeed,
24 Jul 2007:
Biopharmaceuticals, Dermatology, FDA[Anika Therapeutics, Galderma Pharma, ELEVESS, hyaluronic acid]
Barr Confirms Patent Challenge of Aggrenox(R)
HSMN NewsFeed,
12 Jul 2007:
Biopharmaceuticals, Generics[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Aggrenox]
Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
HSMN NewsFeed,
11 Jul 2007:
Biopharmaceuticals[Boehringer Ingelheim, RE-NOVATE trial, dabigatran, venous thromboembolism]
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
HSMN NewsFeed,
6 Jul 2007:
Biopharmaceuticals, HIV/AIDS[Tibotec Therapeutics, PREZISTA, darunavir, TITAN study, antiretroviral]
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
HSMN NewsFeed,
5 Jul 2007:
Biopharmaceuticals, HIV/AIDS[Tibotec Therapeutics, PREZISTA, darunavir]
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
HSMN NewsFeed,
22 Jun 2007:
Biopharmaceuticals, Generics, FDA[Ranbaxy Pharmaceuticals, Boehringer Ingelheim, Tamsulosin, Flomax]
NanoMed Pharmaceuticals Hires Chief Scientific Officer
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Personnel[NanoMed Pharmaceuticals]
Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir) capsules in Diverse Group of Highly Treatment-Experienced HIV Patients
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals, HIV/AIDS[Boehringer Ingelheim, Aptivus, tipranavir, SPRING study]
Lewis T. 'Rusty' Williams, M.D., Ph.D. Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, Personnel[Juvaris BioTherapeutics]
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
HSMN NewsFeed,
23 May 2007:
Biopharmaceuticals, Urology[Spectrum Pharmaceuticals, ozarelix, benign prostatic hypertrophy]
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals, Personnel[Penwest Pharmaceuticals]
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Generics[Roxane Laboratories, Zolpidem, AMBIEN, Sanofi-Aventis]
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Personnel[Ipsen]
Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
HSMN NewsFeed,
12 Apr 2007:
Biopharmaceuticals, Dermatology, Regulatory[Anika Therapeutics, Galderma, ELEVESS]
Bentley Announces Approval for Tamulosin in Spain
HSMN NewsFeed,
22 Mar 2007:
Biopharmaceuticals, Generics, Regulatory[Bentley Pharmaceuticals, tamulosin, Vetevel, Boehringer Ingelheim, Flomax]
Spectrum Pharmaceuticals Bolsters Ozarelix Team with Addition of In-House Urology Expert Bela S. Denes, MD, FACS
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Urology, Personnel[Spectrum Pharmaceuticals]
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
HSMN NewsFeed,
7 Feb 2007:
Biopharmaceuticals, Personnel[Anavex Life Sciences]
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
HSMN NewsFeed,
25 Jan 2007:
Biopharmaceuticals, Urology[Spectrum Pharmaceuticals, ozarelix, benign prostate hypertrophy]
Lannett to Commence Marketing Meloxicam for Arthritis
HSMN NewsFeed,
11 Jan 2007:
Biopharmaceuticals, Generics[Lannett Company, Meloxicam, Boehringer Ingelheim, Mobic]
Idenix Pharmaceuticals, Inc. Announces Appointment of Douglas Mayers, M.D. as Executive Vice President and Chief Medical Officer
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Personnel[Idenix Pharmaceuticals]
ORTHOVISC(R) Clinical Study Commenced To Expand Usage
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Orthopaedic[Anika Therapeutics, DePuy Mitek, ORTHOVISC, osteoarthritis]
Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix IND and Approval of Phase 2b Protocol in BPH (Benign Prostate Hypertrophy)
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Urology[Spectrum Pharmaceuticals, ozarelix, Benign Prostate Hypertrophy]
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
HSMN NewsFeed,
26 Dec 2006:
Biopharmaceuticals, Drug Delivery, Licensing[ImmunoGen, Tumor-Activated Prodrug, sanofi-aventis]
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
HSMN NewsFeed,
21 Dec 2006:
Biopharmaceuticals, Dermatology, FDA[Anika Therapeutics, cosmetic tissue augmentation, hyaluronic acid]
ORTHOVISC(R) Receives Unique Reimbursement Code
HSMN NewsFeed,
15 Dec 2006:
Biopharmaceuticals, Orthopaedic, Reimbursement[Anika Therapeutics, ORTHOVISC, hyaluronic acid]
Vion Pharmaceuticals Enters Into Manufacturing Agreement for Cloretazine(R) (VNP40101M) With Ben Venue Laboratories
HSMN NewsFeed,
13 Dec 2006:
Biopharmaceuticals[Vion Pharmaceuticals, Cloretazine, Ben Venue Laboratories]
Positive Phase 3 Results for New Fixed Oral Dose Anticoagulant Presented at 48th Annual Meeting of the American Society of Hematology
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals[Boehringer Ingelheim Pharmaceuticals, dabigatran]
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
HSMN NewsFeed,
27 Nov 2006:
Biopharmaceuticals, Licensing[Biota Holdings Limited, Boehringer Ingelheim, Hepatitis C]
Anika Therapeutics Appoints Constance Garrison as Vice President of Regulatory and Clinical Affairs
HSMN NewsFeed,
13 Nov 2006:
Biopharmaceuticals, Personnel[Anika Therapeutics]
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
HSMN NewsFeed,
10 Nov 2006:
Biopharmaceuticals, FDA[Boehringer Ingelheim, MIRAPEX, pramipexole, Restless Legs Syndrome]
Panacos Appoints Scott McCallister, M.D., Chief Medical Officer
HSMN NewsFeed,
1 Nov 2006:
Biopharmaceuticals, Personnel[Panacos Pharmaceuticals]
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, pramipexole, Parkinson's disease]
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Agreement to Acquire Zantac(R) from Johnson & Johnson and the Pfizer Consumer Healthcare Business
HSMN NewsFeed,
12 Oct 2006:
Biopharmaceuticals, Gastroenterology, Acquisitions[Boehringer Ingelheim, Johnson & Johnson, Pfizer, Zantac, ranitidine]
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Personnel[Archemix]
Watson Names Thomas Russillo as President, U.S. Generics Division
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals, Personnel[Watson Pharmaceuticals]
Pramipexole Safe and Effective in Treating Restless Legs Syndrome, Study Shows
HSMN NewsFeed,
24 Aug 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, pramipexole, restless legs syndrome]
New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
HSMN NewsFeed,
23 Aug 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, Mirapex, pramipexole, Parkinson's disease]
Schering-Plough Appoints Trevor Juniper General Manager, Schering-Plough China
HSMN NewsFeed,
14 Aug 2006:
Biopharmaceuticals, Personnel[Schering-Plough]
Teva Announces Final Approval of Meloxicam Tablets
HSMN NewsFeed,
20 Jul 2006:
Biopharmaceuticals, Generics, FDA[Teva Pharmaceutical, Meloxicam, Boehringer Ingelheim, Mobic, arthritis]
Par Pharmaceutical Receives Final Approval to Market Meloxicam Tablets
HSMN NewsFeed,
19 Jul 2006:
Biopharmaceuticals, Generics, FDA[Par Pharmaceutical Companies, meloxicam, Boehringer Ingelheim, Mobic]
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
HSMN NewsFeed,
19 Jul 2006:
Biopharmaceuticals, Generics, FDA[Caraco Pharmaceutical Laboratories, Meloxicam, Boehringer Ingelheim, Mobic]
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
HSMN NewsFeed,
11 Jul 2006:
Biopharmaceuticals, Licensing[ImmunoGen, Biotest AG, Tumor-Activated Prodrug]
Sykora Named StoneBridge Pharma President
HSMN NewsFeed,
5 Jul 2006:
Biopharmaceuticals, Personnel[StoneBridge Pharma]
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
HSMN NewsFeed,
30 Jun 2006:
Biopharmaceuticals, Personnel[OXiGENE]
Altus Pharmaceuticals Hires Dr. Burkhard Blank as Senior Vice President of Medicine, Regulatory Affairs and Project Management
HSMN NewsFeed,
8 Jun 2006:
Biopharmaceuticals, Personnel[Altus Pharmaceuticals]
MorphoSys and Schering-Plough Sign R&D Agreement
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals[MorphoSys , Schering-Plough, Combinatorial Antibody Library, HuCAL]
Astex Announces New Chief Executive Officer
HSMN NewsFeed,
10 May 2006:
Biopharmaceuticals, Personnel[Astex Therapeutics, Leon Bushara]
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals[ImmunoGen, Genentech]
Altus Pharmaceuticals Appoints Lauren Sabella Vice President, Commercial Development
HSMN NewsFeed,
1 May 2006:
Biopharmaceuticals, Personnel[Altus Pharmaceuticals]
Bedford Laboratories(TM) to Begin Shipping Mitoxantrone Injection USP
HSMN NewsFeed,
11 Apr 2006:
Biopharmaceuticals, Generics[Bedford Laboratories, Mitoxantrone, Novantrone, Serono]
Pramipexole Significantly Improved Symptoms of Restless Legs Syndrome, New Studies Show
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim Pharmaceuticals, Restless Legs Syndrome, pramipexole]
OccuLogix Expands Focus on Age-Related Eye Diseases
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, Ophthalmology, Mergers & Acquisitions[OccuLogix, SOLX , macular degeneration]
Corautus Genetics Reports Fourth Quarter and 2005 Financial Results and Provides Update on Temporary Suspension of GENASIS Trial
HSMN NewsFeed,
20 Mar 2006:
Biopharmaceuticals, Cardiology[Corautus Genetics, Boston Scientific, GENASIS trial, VEGF-2, angina]
Ventiv Health Expands Contract Sales Agreement with Boehringer Ingelheim
HSMN NewsFeed,
8 Mar 2006:
Biopharmaceuticals[Ventiv Health, Boehringer Ingelheim]
Roxane Laboratories, Inc. Resumes Shipments of Fluticasone Propionate Nasal Spray, 50 mcg
HSMN NewsFeed,
7 Mar 2006:
Biopharmaceuticals, Generics[Roxane Laboratories, Fluticasone, GlaxoSmithKline, FLONASE]
MedImmune Promotes Smullen to Senior Vice President, Sales
HSMN NewsFeed,
27 Feb 2006:
Biopharmaceuticals, Personnel[MedImmune]
Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)
HSMN NewsFeed,
15 Feb 2006:
Biopharmaceuticals[Eli Lilly, Boehringer Ingelheim, Yentreve, AriClaim, duloxetine]
XOMA Announces Senior Management Appointments
HSMN NewsFeed,
12 Jan 2006:
Biopharmaceuticals, Personnel[XOMA]
Additional items found: The Network Archive contains
131 additional itemsBoehringer Ingelheim
Public
Feeds 
Full text >>